KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer
| Image |  |
|---|---|
| Description | scientific article published on April 2009 |
| Author/s |
author: Robert Sandler |
| Publication date | April 1, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |